ABSTRACT
@#Objective To investigate the application of body mass monitoring APP in continuation care of discharged patients with chronic heart failure (CHF).Methods From June, 2016 to June, 2017, 84 patients with CHF were randomly divided into control group and research group with 42 cases in each group. After discharge, the control group received routine continuation nursing and the body mass monitor APP was used to monitor the body mass and continue nursing in the research group. Results After six months of discharge, the N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, and the score of Minnesota Life Heart Failure Quality (MLHFQ) were significantly lower in the research group than in the control group (t>4.712, P<0.001). The number of repeat hospitalizations was lower in the research group than in the control group (χ2=7.714, P<0.01).Conclusion The body mass monitoring APP could improve the symptoms of heart failure and reduce the readmission rate of discharged patients with CHF in continuation care.
ABSTRACT
Objective To investigate the clinical efficacy of Telmisartan combined with Atorvastatin in treating patients with idiopathic paroxysmal atrial fibrillation(IPAF).Methods 70 cases of IPAF were randomly divided into study group(given treatment of Telmisartan combined with Atorvastatin)and control group(given treatment of Telmisartan),35 cases in each group,all patients got 2 years follow-up visit.The change of CRP and the arrhythmia recurrence were observed after treatment.Results After surgery,patients were better than before,but the efficiency in study group was significantly higher than control group(88.6％ vs 68.6％,P ＜0.05);CRP of the two groups were significantly reduced after treatment,two groups have significant difference(P ＜ 0.05).Conclusion Curative effect of atorvastatin combined with telmisartan on IPAF is better than that of telmisartan treatment and clinical implementation should be promoted.